Nalmefene Hydrochloride

CHEMBL1201152 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
375.9 g/mol
LogP
—
Phase
4

This is the hydrochloride salt form of nalmefene used for the same alcohol reduction indications.

น้ำหนักโมเลกุล

375.9000 g/mol

TPSA

52.90 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5.Cl

InChI

InChI=1S/C21H25NO3.ClH/c1-12-6-7-21(24)16-10-14-4-5-15(23)18-17(14)20(21,19(12)25-18)8-9-22(16)11-13-2-3-13;/h4-5,13,16,19,23-24H,1-3,6-11H2;1H/t16-,19+,20+,21-;/m1./s1

Molecular Formula

C21H26ClNO3

HBD / HBA

3 / 4

พันธะที่หมุนได้

2

อะตอมหนัก

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

This is the hydrochloride salt form of nalmefene used for the same alcohol reduction indications.

Yes, Nalmefene Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201152. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5388881. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-08-20.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.